Regulations.gov document
Bioequivalence Recommendations for Budesonide Extended-Release Tablets; Draft Guidance for…
Notice · FDA-2007-D-0369 · posted Dec 11, 2014
Key facts
| Document ID | FDA-2007-D-0369-0308 |
|---|---|
| Title | Bioequivalence Recommendations for Budesonide Extended-Release Tablets; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2007-D-0369 |
| Posted | Dec 11, 2014 |
| Federal Register citation | FR 79 73600 |
| FR document number | 2014-29035 |
| Comment period opens | Dec 11, 2014 |
| Comments due | Feb 10, 2015 |
At a glance
- 1–9 Pages
- No Open for comment
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: